We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $289B
1-Year Est. Return 60.46%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
-4.62%
1 Year Est. Return
+60.46%
3 Year Est. Return
+148.24%
5 Year Est. Return
+163.86%
10 Year Est. Return
+570.16%
AUM
$74.4B
AUM Growth
+$4.15B
Cap. Flow
+$8.44B
Cap. Flow %
11.35%
Top 10 Hldgs %
19.16%
Holding
4,480
New
238
Increased
1,135
Reduced
2,408
Closed
335

Sector Composition

Rank Sector Weight
1 Technology 12.15%
2 Consumer Discretionary 6.92%
3 Financials 5.66%
4 Healthcare 5.15%
5 Industrials 3.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAVE icon
3626
Global X US Infrastructure Development ETF
PAVE
$14.3B
$9.47K ﹤0.01%
+335
New +$9.1K
MPX
3627
DELISTED
Marine Products Corp
MPX
$9.47K ﹤0.01%
820
-1,041
-56% -$12.6K
MFGP
3628
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$9.37K ﹤0.01%
1,768
SURF
3629
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$9.17K ﹤0.01%
3,119
-7,128
-70% -$25K
AOR icon
3630
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.75B
$9.06K ﹤0.01%
168
-1,195
-88% -$65.1K
FBIO icon
3631
Fortress Biotech
FBIO
$97.7M
$9.06K ﹤0.01%
444
-601
-58% -$16.5K
INFI
3632
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$8.96K ﹤0.01%
7,861
-42,917
-85% -$51.3K
TRVN
3633
DELISTED
Trevena, Inc.
TRVN
$8.93K ﹤0.01%
26
-58
-69% -$18.3K
ICAD
3634
DELISTED
iCAD Inc
ICAD
$8.79K ﹤0.01%
1,971
-2,779
-59% -$14K
PSEC icon
3635
Prospect Capital
PSEC
$1.17B
$8.76K ﹤0.01%
1,058
TISI icon
3636
Team
TISI
$101M
$8.63K ﹤0.01%
391
-840
-68% -$8.73K
DJP icon
3637
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$817M
$8.53K ﹤0.01%
231
-214
-48% -$7.18K
AIRG icon
3638
Airgain
AIRG
$69.6M
$8.47K ﹤0.01%
+1,117
New +$10.2K
CELC icon
3639
Celcuity
CELC
$4.36B
$8.39K ﹤0.01%
897
-1,226
-58% -$12.8K
SCNI
3640
Scinai Immunotherapeutics
SCNI
$1.25M
$8.3K ﹤0.01%
+50
New +$7.26K
SYRE icon
3641
Spyre Therapeutics
SYRE
$9.04B
$8.23K ﹤0.01%
143
-303
-68% -$25.4K
DIT icon
3642
AMCON Distributing
DIT
$68.3M
$8.23K ﹤0.01%
80
-51
-39% -$5.8K
AMPE
3643
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$8.1K ﹤0.01%
57
-81
-59% -$11.8K
WVE icon
3644
Wave Life Sciences
WVE
$1.04B
$7.46K ﹤0.01%
3,730
-6,208
-62% -$15.2K
BCEL
3645
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$7.35K ﹤0.01%
2,320
-37,874
-94% -$91.9K
KALA icon
3646
KALA BIO
KALA
$17.2M
$7.32K ﹤0.01%
2
-177
-99% -$464K
HEP
3647
DELISTED
Holly Energy Partners, L.P.
HEP
$7.09K ﹤0.01%
401
-14,459
-97% -$256K
SEEL
3648
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$6.94K ﹤0.01%
2
-3
-60% -$12.9K
CIX icon
3649
Comp X International
CIX
$386M
$6.7K ﹤0.01%
285
-620
-69% -$14K
SLQD icon
3650
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.38B
$6.66K ﹤0.01%
135
-21,137
-99% -$1.06M

Similar funds

BNP Paribas Financial Markets's Q1 2022 Portfolio in Review

As of Q1 2022, BNP Paribas Financial Markets held 4,480 positions worth $74.4B, up 5.9% from $70.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

BNP Paribas Financial Markets deployed $8.44B of net new capital in Q1 2022, opening 238 new positions and adding to 1,135 existing holdings. Its largest new stake was Invesco Emerging Markets Sovereign Debt ETF: 1,028,214 shares worth $23.2M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $283M trimmed.

  • BNP Paribas Financial Markets's largest Q1 2022 buy was Invesco Emerging Markets Sovereign Debt ETF: 1,028,214 shares worth $23.2M.
  • BNP Paribas Financial Markets added most to Invesco QQQ Trust in Q1 2022, an estimated $2.42B increase.
  • BNP Paribas Financial Markets's biggest Q1 2022 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $283M.
  • BNP Paribas Financial Markets fully exited Xilinx Inc in Q1 2022, selling an estimated $301M.
  • BNP Paribas Financial Markets's ten largest holdings make up 19% of its $74.4B portfolio in Q1 2022.
  • BNP Paribas Financial Markets opened 238 new positions and closed 335 in Q1 2022.
  • BNP Paribas Financial Markets's portfolio value rose 5.9% quarter-over-quarter to $74.4B.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2022, filed 17 May 2022.